- 27 Feb 2020, 16:30
#3404
Solomon Benny wrote:Steps for conducting any pharmacoeconomic analysis are as follows:May be not. Its done at the end to exclude the uncertainty from your study results. If any confounding factors affects your results.
(1) defining the problem,
(2) determining the study's perspective,
(3) determining the alternatives and outcomes,
(4) selecting the appropriate pharmacoeconomic method,
(5) placing monetary values on the outcomes,
(6) identifying study resources,
(7) establishing the probabilities of the outcomes,
(8) applying decision analysis,
(9) discounting costs or performing a sensitivity or incremental cost analysis, and
(10) presenting the results, along with any limitations of the study. By adhering to the analytic steps described, the pharmacist undertaking a pharmacoeconomic evaluation has the greatest likelihood of obtaining valid and useful results.
Can we use the same procedure for sensitivity analysis also?